ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-PO891

Sex Disparity and Kidney Function in Living Kidney Donors

Session Information

Category: Transplantation

  • 2102 Transplantation: Clinical

Authors

  • Tantisattamo, Ekamol, University of California Irvine School of Medicine, Irvine, California, United States
  • Rochanaroon, Voramol, Rayong Hospital, Rayong, Thailand
  • Noree, Wanprapit, Police General Hospital, Bangkok, Thailand
  • Thiravetyan, Ben, Mahidol University Faculty of Medicine Siriraj Hospital, Bangkok, Thailand
  • Suenghataiphorn, Thanathip, Mahidol University Faculty of Medicine Siriraj Hospital, Bangkok, Thailand
  • Chuenchaem, Urairat, Bumrungrad International Hospital, Bangkok, Thailand
  • Kulthamrongsri, Narathorn, Mahidol University Faculty of Medicine Siriraj Hospital, Bangkok, Thailand
  • Srikulmontri, Thitiphan, Siriraj Health Science Education Excellence Center, Mahidol University Faculty of Medicine Siriraj Hospital, Bangkok, Thailand
  • Puchongmart, Chanokporn, Mahidol University Faculty of Medicine Siriraj Hospital, Bangkok, Thailand
  • Naunsil, Piengpich, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
  • Vutthikraivit, Possawat, Phramongkutklao College of Medicine, Mahidol University, Bangkok, Thailand
  • Tanariyakul, Manasawee, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii, United States
  • Leesutipornchai, Thiratest, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii, United States
  • Kittrakulrat, Jathurong, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
  • Kunupakan, Sasithorn, University of California Irvine School of Medicine, Irvine, United States
  • Wattanachayakul, Phuuwadith, University of California Irvine School of Medicine, Irvine, United States
Background

While a sex disparity in chronic kidney disease exists, it remains unclear if there is a disproportionate difference in kidney function following kidney donation.

Methods

A retrospective cohort study using OPTN/SRTR includes adult living kidney donors (LKD) undergoing donation between June 1972 and September 2022. The time-to-event of >35% rise in post-donation serum creatinine (SCr) from pre-donation SCr between female and male LKD was investigated by multiple Cox proportional hazard regression.

Results

In a cohort of 136,814 living kidney donors, mean±SD age was 42±12 years and 61% were female. Out of 103,938 LKD with post-donation SCr data at 6, 12, or 24 months, 75,343 (72%) experienced the event within a median time to follow-up of 6.3 months (IQR 4.1, 8.7). The incidence rate of the event was 0.09 person-months. The mean and median pre-donation SCr was 0.85±0.19 and 0.80 mg/dL, respectively with notably female and male mean pre-donation SCr were 0.77±0.14 and 0.99±0.17 mg/dL, respectively (mean difference of 22%; (95%CI 0.22, 0.22; P <0.001). Compared to female LKD, male LKD had a 12% significantly higher risk of experiencing an increased post-donation SCr >35% (HR 1.12; 95%CI 1.10, 1.13; P <0.001). After adjusting for age, race/ethnicity, U.S. citizenship, education level, history of pre-donation hypertension, pre-donation BMI, SBP, DBP, post-donation proteinuria, and the interaction term between sex and pre-donation SCr (≤0.8 or >0.8), male LKD remained at a significantly higher risk for the event (HR 1.42; 95%CI 1.36, 1.47; P <0.001). Furthermore, pre-donation SCr was identified as an effect modifier with an increased risk of rising SCr >35% observed in male LKD with pre-donation SCr >0.8 mg/dL (Pinteraction <0.001).

Conclusion

Male LKD with pre-donation SCr >0.8 mg/dL are at a higher risk of experiencing an increased post-donation SCr >35% compared to female LKD regardless of other pre- and post-donation factors. Despite women contributing as LKD more than men, addressing the underlying causes of sex disparity may provide the opportunity to increase donations while taking precaution for high-risk population.